(NEW YORK) — Here are today’s In Crisis headlines:
COVID-19 numbers
Here’s the latest data on COVID-19 coronavirus infections and deaths.
Latest reported numbers globally per Johns Hopkins University
Global diagnosed cases: 38,195,651
Global deaths: 1,087,343. The United States has the most deaths of any single country, with 215,914.
Number of countries/regions: at least 188
Total patients recovered globally: 26,507,421
Latest reported numbers in the United States per Johns Hopkins University
There are at least 7,859,365 reported cases in 50 states + the District of Columbia, Puerto Rico and Guam. This is more than in any other country.
U.S. deaths: at least 215,914. New York State has the greatest number of reported deaths in the U.S., with 33,306.
U.S. total patients recovered: 3,124,593
U.S. total people tested: 117,357,626
The greatest number of reported COVID-19 cases in the U.S. is in California, with 862,237 confirmed cases out of a total state population of 39.51 million. That ranks third in the world after Maharashtra, India, which has 1,543,837 reported cases, and Sao Paulo, Brazil, which has 1,039,029 reported cases.
Global COVID-19 cases top 38 million as US cases continue to increase
The number of reported COVID-19 cases in the world topped 38 million Tuesday night, according to data compiled by Johns Hopkins University, fewer than five days after it surpassed 37 million. At the current rate, the number of infections could exceed 39 million by the end of the week. The World Health Organization said more than 2.2 million new cases of COVID-19 and 39,000 deaths from the disease have been reported across the globe in the past week, the highest number of reported cases in a single week since the start of the pandemic. According to the WHO’s weekly epidemiological update, published Monday, Europe registered the highest weekly incidence of COVID-19 cases of any region since the start of the pandemic, with almost 700,000 new infections reported. Even so, the actual numbers are believed to be much higher due to testing shortages, many unreported cases and suspicions that some national governments are hiding or downplaying the scope of their outbreaks.
In the U.S., COVID-19 cases also continue to rise, with 34 states and territories currently experiencing an upward trajectory of new cases, according to a Department of Health and Human Services memo obtained by ABC News. Some 351,270 new cases were confirmed during the period of October 6-12 – a 14.4% increase from the previous seven-day period. The national test-positivity rate rose from 4.7% to 6.1% in week-to-week comparisons, while 22% of hospitals across the country reported having more than 80% of their ICU beds filled. That number was 17%-18% during the summertime peak.
Wisconsin continues to be one of the states experiencing one of the most rapid COVID-19 infection increases. Andrea Palm, the state’s top health official, urged residents Tuesday to “stay home as much as you can” amid record deaths and new coronavirus cases. Hospitalizations have nearly tripled over the last month, while a 530-bed military field hospital opens this morning outside Milwaukee to deal with patients from hospitals that exceed capacity.
Another COVID-19 vaccine trial is put on hold
One day after Johnson & Johnson paused its phase 3 COVID-19 vaccine trial after a volunteer reported an unidentified illness, the phase 3 trial for Eli Lilly’s monoclonal antibody COVID-19 treatment is on hold because of a potential safety concern. Enrollment was paused in a study testing the COVID-19 antiviral drug remdesivir, plus an experimental antibody therapy being developed by Eli Lilly that’s similar to a treatment President Trump recently received. Lilly confirmed Tuesday that the study had been paused “out of an abundance of caution.” Johnson & Johnson executives said Tuesday that it will be a few days before they know more about the unexplained illness in one participant that caused the pause in its late-stage vaccine study. This makes the third major pharmaceutical company to pause its vaccine human trials due to an illness in a participant. A phase 3 human trial, often involving thousands of participants, is the last step before a drug’s authorization or approval. According to The New York Times, there are currently 11 vaccines in phase three trials around the world.
Copyright © 2020, ABC Audio. All rights reserved.